SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ASP Isotopes Inc. (ASPI) News

Track canonical SquawkNews coverage tagged to ASPI, ASP Isotopes Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 19 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ASPI Asset equity Sector Markets 90 days 15 Last 2.93 Updated Sep 08, 2026, 08:39 PM UTC Open live news feed
L ASPI targets $300–$700M EBITDA by 2031 on global scaling ASPI says it is transitioning from development to global scaling, targeting $300–$700 million EBITDA by 2031 via expansion across radiopharmaceuticals, isotope enrichment, helium/LNG, and nuclear fuel. EQUITY | Sep 08, 2026, 08:39 PM UTC L ASPI targets $300–$700M EBITDA by 2031 via global expansion ASPI says it is scaling globally and targeting $300–$700 million EBITDA by 2031 through expansion in radiopharmaceuticals, isotope enrichment, helium/LNG, and electronic gases, supported by proprietary technologies and d EQUITY | Sep 08, 2026, 06:29 PM UTC L ASPI highlights expansion and targets over $300M 2031 EBITDA ASPI says four divisions are scaling, citing proprietary enrichment tech at commercial scale and strong financial position. Milestones include new plant launches, global radiopharmacy expansion, and partnerships, plus a EQUITY | Sep 08, 2026, 04:22 PM UTC L ASP Isotopes targets over $300 million EBITDA in 2031 ASP Isotopes said it targets more than $300 million of EBITDA in 2031. EQUITY | Sep 08, 2026, 02:54 PM UTC M ASP Isotopes outlines commercialization milestones and $300M EBITDA target ASP Isotopes said at its inaugural Capital Markets Day in London that it is transitioning from development into early commercialization, with milestones intended to drive revenues and a $300 million EBITDA target for 203 REGULATION | Sep 08, 2026, 01:23 PM UTC L ASP Isotopes hosts inaugural Capital Markets Day in London ASP Isotopes Inc. is hosting its inaugural Capital Markets Day in London, alongside a provided operational update. EQUITY | Sep 08, 2026, 01:17 PM UTC L ASPI - ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update ASPI - ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update EQUITY | Sep 08, 2026, 01:15 PM UTC H ASPI subsidiary starts commissioning South Africa liquid helium plant Asp Isotopes (ASPI) says Renergen Limited’s subsidiary has commenced commissioning of its South Africa liquid helium plant, targeting customer deliveries in September. ENERGY | Aug 20, 2026, 12:03 PM UTC M ASP Isotopes says Renergen subsidiary starts liquid helium plant commissioning ASP Isotopes Inc. says a subsidiary of Renergen Limited has commenced commissioning of a liquid helium plant in South Africa, according to a company announcement. ENERGY | Aug 20, 2026, 12:00 PM UTC M ASPI Isotopes: Quantum Leap Energy evaluates metal conversion in Namibia ASPI Isotopes says Quantum Leap Energy is evaluating metal conversion opportunities in Namibia, with no further details or quantitative impact provided in the alert. ENERGY | Aug 18, 2026, 12:01 PM UTC L ENDRA Life Sciences reports Q2 2026 financial results; provides business update ENDRA Life Sciences (ASPI) reports second quarter 2026 financial results and provides a business update, according to a TradeXchange Newsdesk release. EARNINGS | Aug 17, 2026, 12:09 PM UTC M South Africa Renergen Subsidiary Enters LNG Supply Contract Renergen subsidiary signs take-or-pay contract for LNG supply ENERGY | Aug 06, 2026, 12:00 PM UTC L ASPI to Participate in Canaccord Conference ASPI attends conference on August 12 EQUITY | Jul 30, 2026, 12:00 PM UTC L ASPI announces qle agreement with Texas a&m engineering experiment Station to advance Uranium conversion technology Asp Isotopes - agreement ASPI announces qle agreement with Texas a&m engineering experiment Station to advance Uranium conversion technology Asp Isotopes - agreement advances qle's scalable domestic Uranium conversion technology for U.S. Nuclear EQUITY | Jul 21, 2026, 12:17 PM UTC L ASPI - Asp Isotopes Files Prospectus Related To Offer & Sale By Selling Stockholders Of 23.2M Shares Of Common Stock ASPI - Asp Isotopes Files Prospectus Related To Offer & Sale By Selling Stockholders Of 23.2M Shares Of Common Stock EQUITY | Jul 16, 2026, 09:07 PM UTC H ASPI Merging with ENDRA ASP Isotopes announces proposed merger of Noble Africa with ENDRA Life Sciences and $50 million private placement financing EQUITY | Jun 25, 2026, 02:04 PM UTC H ASPI Subsidiary Merging ASP Isotopes' subsidiary Noble Africa is merging with ENDRA Life Sciences subsidiary and plans to trade on Nasdaq under NOBA ticker EQUITY | Jun 25, 2026, 01:37 PM UTC H ASPI Merging Noble Africa ASP Isotopes announces proposed merger of Noble Africa with ENDRA Life Sciences and $50 million private placement financing EQUITY | Jun 25, 2026, 01:30 PM UTC M ASPI: Renergen Subsidiary Signs Helium Supply Deal ASPI announces subsidiary of Renergen Limited enters take-or-pay contract for helium supply from Virginia Gas Project in South Africa ENERGY | Jun 23, 2026, 12:01 PM UTC